ArticleEClinicalMedicine2023

Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study.

Nicholas Michael Croft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.